The interaction between PoFbx23A and PoAce1. by Zhongjiao Liu (11877464)

Subjects:

Subcellular localization of PoFbx23A and PoAce1. by Zhongjiao Liu (11877464)

Subjects:

Saturation analysis of transcriptome data for the WT and Δ<i>fbx23</i>. by Zhongjiao Liu (11877464)

Subjects:

Construction strategies for GFP strains Ace1/Fbx23-GFP and BiFC strain Ace1-YFP-Fbx23. by Zhongjiao Liu (11877464)

Subjects:

Construction strategy and verification of strains Ace1/Fbx23-TAP, Δ<i>fbx23</i>, and Re<i>fbx23</i>. by Zhongjiao Liu (11877464)

Subjects:

Phylogenetic and domain architecture analysis of PoAce1 orthologs. by Zhongjiao Liu (11877464)

Subjects:

GO enrichment analysis of the differentially expressed genes between the WT and the Δ<i>fbx23</i> grown in VMMC. by Zhongjiao Liu (11877464)

Subjects:

The effect of PoFbx23 on the PoAce1 protein abundance and transcription levels of genes encoding plant cell wall-degrading enzymes under cellulose signal. by Zhongjiao Liu (11877464)

Subjects:

The results of TAP-MS using PoFbx23 as bait. by Zhongjiao Liu (11877464)

Subjects:

Data that underlies the TAP-MS of two Fbx23-TAP samples. by Zhongjiao Liu (11877464)

Subjects:

The result of TAP-MS using PoFbx23 as the bait. by Zhongjiao Liu (11877464)

Subjects:

Transcriptome analysis of secondary metabolism gene clusters of the WT and Δ<i>fbx23</i> grown in VMMG. by Zhongjiao Liu (11877464)

Subjects:

Data that underlies the transcriptome in this paper. by Zhongjiao Liu (11877464)

Subjects:

The differentially expressed genes in transcriptome. by Zhongjiao Liu (11877464)

Subjects:

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice treated with 0.5% bupivacaine (BUP) combined with topical (TOP) application, following subconjunctival injection (SCI) of CGRP, 24 hours before the final BUP treatment (day 14) and again one hour prior to the final bupivacaine injection on day 15. by Ananya Datta (19932144)

Table 2_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

“…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I² = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I² = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I² = 65.5%). …”

Table 1_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

“…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I² = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I² = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I² = 65.5%). …”

Table 3_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

“…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I² = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I² = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I² = 65.5%). …”

Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (demographics in S4 Table) before vaccination (D0) and 90 days post-vaccination (D90) were combined ex vivo and stimulated with VZV-rgE. A subset of D0 monocyte & NK cocultures was also treated with the TGFβ1 inhibitor LY (D0 LY), and a subset of D90 cocultures were supplemented with rhTGFβ1. The graph shows individual data points, means and p values calculated by Friedman test for repeated measures with FDR correction. LY treatment of cells collected on D0 significantly increased their activation to levels similar to D90. Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0. by Michael J. Johnson (5818168)

“…Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.…”

Comparison of body weight and food intake of rats in each group. by Shudan Liu (7049483)

Subjects: